Profile data is unavailable for this security.
About the company
Taiyen Biotech Co., Ltd is a Taiwan-based company mainly engaged in the manufacture, distribution and trading of salt products, salt by-products and other salt derivatives. The Company offers salt products, skin care and cosmetics, bottled water products, facial and body cleansers, health and dietary supplements, as well as other products, such as collagen raw materials, biomedical materials, microbial agents and others. The Company’s salt products include fine salts, dried salts, low sodium salts, bay salts and other salts, which are applied in industry, agriculture, food processing, cooking and others. The Company distributes its products in Taiwan market and to overseas markets.
- Revenue in TWD (TTM)3.36bn
- Net income in TWD296.64m
- Incorporated1995
- Employees487.00
- LocationTaiyen Biotech Co LtdNo. 297, Section 1Chien-Kang Road, South DistrictTAINAN 702TaiwanTWN
- Phone+886 62160688
- Fax+886 62160678
- Websitehttps://www.tybio.com.tw/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fwusow Industry Co Ltd | 15.63bn | 299.53m | 6.33bn | 899.00 | 21.13 | 1.38 | 10.29 | 0.4052 | 0.9039 | 0.9039 | 47.17 | 13.84 | 1.62 | 5.80 | 11.44 | 17,179,000.00 | 3.10 | 3.51 | 4.78 | 5.12 | 9.27 | 9.16 | 1.92 | 2.24 | 0.8135 | -- | 0.4597 | 63.68 | -4.03 | 6.86 | -2.91 | -- | -6.13 | 38.79 |
| Taiyen Biotech Co Ltd | 3.36bn | 296.64m | 6.85bn | 487.00 | 23.12 | 1.04 | 17.76 | 2.04 | 1.48 | 1.48 | 16.75 | 32.98 | 0.4056 | 5.41 | 5.03 | -- | 2.40 | 4.45 | 2.73 | 5.08 | 37.58 | 37.45 | 5.91 | 10.36 | 2.67 | -- | 0.036 | 77.01 | -5.67 | 2.58 | -29.60 | -7.88 | 2.75 | -7.79 |
| Sunjuice Holdings Co Ltd | 4.63bn | 419.92m | 7.21bn | 272.00 | 17.17 | 1.91 | 9.74 | 1.56 | 12.40 | 12.40 | 136.84 | 111.80 | 0.9671 | 7.09 | 13.01 | -- | 10.02 | 14.90 | 12.64 | 19.26 | 28.13 | 34.90 | 10.36 | 14.64 | 4.03 | -- | 0.013 | 52.45 | 12.94 | 7.53 | 4.12 | -1.00 | -13.86 | 3.21 |
| Wei Chuan Foods Corp. | 22.02bn | 271.85m | 9.69bn | 6.55k | 35.65 | 1.31 | 7.12 | 0.4401 | 0.5372 | 0.5372 | 43.52 | 14.62 | 1.20 | 9.22 | 8.73 | -- | 1.49 | 3.15 | 2.45 | 5.07 | 27.21 | 28.61 | 1.24 | 2.90 | 0.6647 | 3.39 | 0.4383 | 50.05 | 7.53 | 2.02 | 11.67 | -22.86 | -16.46 | -19.77 |
Data as of May 17 2024. Currency figures normalised to Taiyen Biotech Co Ltd's reporting currency: Taiwan Dollar TWD
5.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 09 May 2024 | 4.47m | 2.23% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 2.51m | 1.26% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 2.10m | 1.05% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 720.08k | 0.36% |
| FIL Investments Internationalas of 30 Jun 2023 | 229.00k | 0.12% |
| Acadian Asset Management LLCas of 30 Sep 2023 | 220.66k | 0.11% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 128.44k | 0.06% |
| DFA Australia Ltd.as of 31 Mar 2024 | 51.28k | 0.03% |
| American Century Investment Management, Inc.as of 09 May 2024 | 30.00k | 0.02% |
| Vanguard Global Advisers LLCas of 30 Apr 2024 | 14.00k | 0.01% |
More ▼
Data from 31 Dec 2023 - 16 May 2024Source: FactSet Research Systems Inc.
